Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. (Q53294096)

13 May 2018

title

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. (English)

1 reference

13 May 2018

0 references

2

Meijer CJ

1 reference

13 May 2018

author name string

Muris JJ

1

1 reference

13 May 2018

Cillessen SA

3

1 reference

13 May 2018

Vos W

4

1 reference

13 May 2018

Kummer JA

5

1 reference

13 May 2018

Bladergroen BA

6

1 reference

13 May 2018

Bogman MJ

7

1 reference

13 May 2018

MacKenzie MA

8

1 reference

13 May 2018

Jiwa NM

9

1 reference

13 May 2018

Siegenbeek van Heukelom LH

10

1 reference

13 May 2018

Ossenkoppele GJ

11

1 reference

13 May 2018

Oudejans JJ

12

1 reference

13 May 2018

publication date

1 March 2004

1 reference

13 May 2018

published in

Leukemia

1 reference

13 May 2018

volume

18

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

589-596

1 reference

13 May 2018

Apoptosis: a link between cancer genetics and chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

A molecular model of MHC class-I-restricted antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

21 January 2018

The Extranodal Lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytotoxic T lymphocytes: all roads lead to death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

inferred from DOI database lookup

7 January 2021

based on heuristic

Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403240

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403240

1 reference

13 May 2018

1 reference

13 May 2018